Quick Answer: GLP-1 receptor agonists may reduce alcohol cravings in some individuals, but they are not FDA-approved for treating alcohol use disorder and evidence remains preliminary
He held positions in both Academia (Tbingen, Aachen, and Braunschweig, Germany) and industry (Aachen)
[2] [3] Understanding the full safety profile of GLP-1 medications, including potential effects on vision, remains essential for both prescribers and patients as use of these agents continues to expand rapidly across diverse patient populations
The BBB is a highly specific structure that safeguards the distinct microenvironment of the brain
This will help you determine the benefits of a vitamin B12 injection
Post-treatment, most patients can resume their normal activities immediately, as there is no downtime required